Navigating Intellectual Property Challenges in the Expanding Cannabis and Psychedelics Sectors

The booming cannabis and psychedelics industries are attracting widespread attention, presenting complex intellectual property hurdles. Over the past five months, activity within these sectors has surged, fueled by both government initiatives and commercial expansion. This rapid growth has brought renewed attention to patent strategies and the protection of innovative developments. Companies operating in cannabis and…

Read More

Linklaters Strengthens U.S. Market Presence with Strategic M&A Expert Hire from Wachtell

Linklaters has made a significant move to bolster its New York operations by recruiting a prominent mergers and acquisitions specialist from Wachtell, Lipton, Rosen & Katz. This strategic appointment highlights the firm’s ongoing commitment to expanding its influence in the U.S. market. The acquisition of such a distinguished figure from Wachtell marks a notable enhancement…

Read More

Third Circuit Upholds Dismissal in Ranbaxy Antitrust Case, Solidifying Pay-for-Delay Precedent

The Third Circuit Court of Appeals has declined to revisit its prior decision to uphold a New Jersey district court’s dismissal of an antitrust lawsuit involving Ranbaxy Laboratories Ltd. The case centered around allegations that the pharmaceutical company engaged in a pay-for-delay scheme to postpone the introduction of a generic version of Lipitor, a best-selling…

Read More

Delaware Court Awards Emotion-Recognition Technology to Candor Compass in Landmark Intellectual Property Ruling

The Delaware Court of Chancery has ruled in favor of Candor Compass LLC, mandating that Italian artificial intelligence firm iDentivisuals SRL transfer ownership of its emotion-recognition technology to Candor. The court determined that iDentivisuals breached a binding agreement by failing to deliver and safeguard the licensed technology. iDentivisuals, established in 2016, developed an AI-based emotion…

Read More

U.S. Supreme Court to Review Role of Juries in Trademark Strength Evaluations

In a significant appeal to the U.S. Supreme Court, RiseandShine Corp. has brought forward a pivotal argument concerning the determination of trademark strength. The company has challenged the Second Circuit’s approach, which permits judges to decide the strength of a trademark, suggesting that such evaluations should be conducted by juries. This debate centers around how…

Read More

Champagne Trademark Clash Sheds Light on Litigation Funding Dynamics

The ongoing legal battle between French champagne houses and a Florida-based importer has shed light on the often opaque world of litigation funding. This case has drawn attention to the financial underpinnings that enable such high-stakes legal disputes. The complexities of this transatlantic confrontation are further compounded by the involvement of third-party litigation funders, who…

Read More

U.S. Supreme Court Urged to Expedite Tech Trademark Trial Amid International Dispute

A North Carolina-based software company has urged the U.S. Supreme Court to resist delaying a forthcoming trademark trial with its former Dutch partner, arguing that proceeding with the trial is the most efficient route to resolve the protracted litigation. As expressed during Tuesday’s proceedings, the dispute revolves around a licensing agreement that complicated relations between…

Read More

Trademark Clash: Judge Allows Case Over MSCHF’s ‘Wavy Baby’ Sneaker to Proceed

A New York federal magistrate judge has recommended that a trademark lawsuit involving the artist collective MSCHF move forward. The case centers around MSCHF’s use of “Wavy Baby” for a limited-edition sneaker, which allegedly conflicts with a streetwear company’s trademarked “WaveyBaby” brand. The streetwear company argues that MSCHF’s use of a strikingly similar name is…

Read More

“ArcherDX Seeks Federal Circuit Reversal in Natera Patent Dispute Over Cancer Diagnostic Technologies”

ArcherDX is appealing to the Federal Circuit to overturn a revised verdict in a contentious patent dispute with Natera over cancer diagnostic technology. The case, rooted in allegations of patent infringement by ArcherDX, initially resulted in a $19 million judgment against the company. However, a Delaware federal judge recently reduced this amount by $10 million,…

Read More

North Carolina Supreme Court Tackles Landmark Cases on NIL Rights, Environmental Accountability, and Privacy Concerns

North Carolina’s highest court is poised for a busy September as it reconvenes to hear a series of high-profile legal disputes. First on the docket is a compelling name, image, and likeness (NIL) case initiated by members of North Carolina State University’s 1983 championship basketball team against the NCAA. The players assert that they were…

Read More

Winston Taylor Expands in Miami: Strategic Move Taps into Growing Legal and Economic Hub

Winston Taylor’s strategic expansion into Miami is attracting attention as the firm explores the growing opportunities within this vibrant market. As explained by Gustavo J. Membiela, Miami Managing Partner, the firm’s focus since entering the city in 2022 has been on leveraging local dynamics that align with broader strategic goals, including access to Latin American…

Read More

Winstead PC Expands Houston Real Estate Practice with Strategic Hire of Former GC Sindhu Khatter

In a strategic move to bolster its capabilities, Winstead PC has announced the addition of former General Counsel Sindhu Khatter to its Houston real estate practice. Her transition from an in-house role marks a significant step, reflecting the firm’s commitment to strengthening its real estate legal services. Khatter, who was previously at Transwestern, brings a…

Read More

Federal Judge Blocks Trump-Era Orders Challenging Birthright Citizenship Rights

In a significant legal ruling, US District Judge Deborah Boardman has issued a preliminary injunction against the enforcement of dual executive orders from the Trump administration aimed at curtailing birthright citizenship. These orders, announced in August 2026, sought to revoke citizenship from children born to parents unlawfully or temporarily in the United States, addressing concerns…

Read More

King & Spalding Amplifies New York Litigation Strength with Strategic Hire from Cooley LLP

In a notable move that underscores the competitive dynamics of the legal industry, King & Spalding has strengthened its litigation team with the addition of Kevin Smith, a seasoned commercial litigator from Cooley LLP. This strategic hire in New York aims to enhance the firm’s capabilities in handling complex commercial disputes. Kevin Smith, whose experience…

Read More

Navigating U.S. Legal Complexities: Challenges and Strategies for Japanese Corporations Expanding Abroad

Japanese corporate executives and general counsels (GCs) are increasingly encountering the stark contrasts between Japan’s legal system and that of the United States. In Japan, litigation is rare and less confrontational. The adversarial posture and invasiveness of U.S. litigation is often disorienting. In Japan, litigation is rare and less confrontational. The adversarial posture and invasiveness…

Read More

“Herbert Smith Freehills Kramer LLP Faces $1 Billion Malpractice Lawsuit with King & Spalding”

Herbert Smith Freehills Kramer LLP and several of its partners have been drawn into a $1 billion legal malpractice lawsuit involving King & Spalding LLP. The lawsuit, filed by White Oak Advisors, alleges that the law firms participated in schemes aimed at benefiting a lawyer’s acquaintance, consequently disadvantaging the investment firm. The addition of HSF…

Read More

California Judge Dismisses Antitrust Claims Against Meta Platforms Due to Statute of Limitations

A recent ruling by a California federal judge has provided Meta Platforms Inc. a temporary reprieve in an antitrust lawsuit filed by a UK-based company. The British firm accused Meta of appropriating its concept for Instagram’s shopping feature. The judge determined that the claims were filed too late, as the alleged infringement occurred years prior…

Read More

Ascendis Pharma and BioMarin Settle Patent Dispute, Paving Way for Enhanced Focus on Genetic Disorder Treatments

Ascendis Pharma and BioMarin Pharmaceutical have reached a legal settlement resolving their patent disputes over treatments for a specific genetic disorder in children. Under the agreement, Ascendis has agreed to pay BioMarin royalties, thus bringing an end to ongoing proceedings at the U.S. International Trade Commission and various court venues, including California federal court. For…

Read More

Linklaters Strengthens U.S. Litigation Practice with Former Johnson & Johnson Executive

Linklaters has made a strategic addition to its New York office by bringing on board a seasoned legal executive from Johnson & Johnson. The firm welcomes Diane Romza-Kutz, who previously served as Vice President of Litigation at J&J, highlighting the firm’s continued expansion of its litigation capabilities. Diane Romza-Kutz brings extensive experience from her tenure…

Read More

Federal Circuit Ruling Bolsters Exelixis Patent Protection, Delays Generic Cabometyx Launch to 2030

The U.S. Court of Appeals for the Federal Circuit recently affirmed that MSN Laboratories’ efforts to introduce a generic version of the cancer treatment Cabometyx, developed by Exelixis, will be on hold. This decision comes after the court rejected MSN’s challenge against the validity of three patents held by Exelixis on the drug. The ruling…

Read More